P.O. Box 1627, FI-70270 Kuopio, Finland,
J Ment Health Policy Econ. 2024 Sep 1;27(3):85-98.
Childhood disruptive behaviour disorder associates with various, also costly problems. Parent training is effective in reducing childhood disruptive behaviour. Only a few studies have evaluated the cost-effectiveness of digital parent training in reducing children's disruptive behaviour.
We evaluated the two-year cost-effectiveness of an Internet and telephone assisted parent training intervention called the Strongest Families Smart Website (SFSW) for prevention of children's disruptive behaviour compared to education control (EC) from the combined perspective of the health care funder and parents.
This study used data from a randomized controlled trial (RCT). The trial screened a population-based sample of 4,656 four-year-olds at annual child health clinic check-ups in Finnish primary care. A total of 464 disruptively behaving children participated in the RCT; half received the SFSW and half EC. We evaluated intention-to-treat based incremental net monetary benefit with a range of willingness to pay values. Costs contained the interventions' and parents' time-use costs. The effectiveness measure was the Child Behavior Checklist (CBCL/1.5-5) externalizing score. The trial is registered at Clinicaltrials.gov (NCT01750996).
From the health care funder's perspective, SFSW costs per family were €1,982 and EC €661, and from the parents' perspective SFSW costs per family were €462 and EC €77. From the combined health care funder and parents' perspective, costs were €1,707 higher in the SFSW intervention than in EC. The SFSW decreased the CBCL externalizing score (1.94, SE=0.78, p=0.01) more in comparison to the EC group. In cost-effectiveness analysis using the combined perspective, the incremental net monetary benefit was zero [95% CI €-1,524 to €1,524] if the willingness to pay for one extra point of CBCL externalizing score reduced was €879. If the willingness to pay was more than €879, the average incremental net monetary benefit was positive.
The cost-effectiveness of the SFSW depends on the decision makers' willingness to pay, which is not stated for CBCL outcomes. Also, the decision maker should consider the uncertainty of cost-effectiveness estimates. The lack of other service use information and micro-costing of SFSW and EC intervention costs weakens our conclusions. However, our study had multiple strengths, such as population-based screening, high sample size, 2-year follow-up, and use of proper methods to conduct a full economic evaluation.
The SFSW is effective in reducing children's disruptive behaviour. Although digitally provided, the SFSW intervention included professional time and, thus, costs. The costs of intervention to the healthcare provider and time cost to families should be taken into account when interventions are implemented. The cost-effectiveness of SFSW interventions depends on the willingness to pay of health care decision makers.
Investment decisions should require high-quality economic evaluation of interventions and independent evaluation research of interventions should be financed.
Decision makers need more economic evaluations of digital interventions. Research should use similar high-quality methods to allow comparison between studies. In an early planning phase of research, health economists should be consulted to enable usability of data and high-quality research.
儿童破坏性行为障碍与各种问题相关,包括昂贵的治疗费用。家长培训在减少儿童破坏性行为方面非常有效。只有少数研究评估了数字家长培训在减少儿童破坏性行为方面的成本效益。
本研究从医疗保健提供者和家长的综合角度评估了名为“Strongest Families Smart Website(SFSW)”的互联网和电话辅助家长培训干预措施与教育对照(EC)相比,预防儿童破坏性行为的两年成本效益。该研究使用了一项随机对照试验(RCT)的数据。该试验对芬兰初级保健年度儿童健康诊所检查中基于人群的 4656 名四岁儿童进行了筛查。共有 464 名行为破坏的儿童参加了 RCT;一半接受了 SFSW,一半接受了 EC。我们根据愿意支付的一系列价值评估了意向治疗的增量净货币收益。成本包含干预措施和家长时间使用成本。有效性衡量标准是儿童行为检查表(CBCL/1.5-5)的外化得分。该试验在 Clinicaltrials.gov (NCT01750996)上注册。
从医疗保健提供者的角度来看,SFSW 每个家庭的成本为 1982 欧元,EC 为 661 欧元,从家长的角度来看,SFSW 每个家庭的成本为 462 欧元,EC 为 77 欧元。从医疗保健提供者和家长的综合角度来看,SFSW 干预的成本比 EC 高 1707 欧元。与 EC 组相比,SFSW 更能降低 CBCL 外化得分(1.94,SE=0.78,p=0.01)。在使用综合视角进行成本效益分析时,如果降低 CBCL 外化得分一个点的意愿支付金额为 879 欧元,则增量净货币收益为零[95%CI-1524 欧元至 1524 欧元]。如果意愿支付金额超过 879 欧元,平均增量净货币收益为正。
SFSW 的成本效益取决于决策者的支付意愿,而对于 CBCL 结果并未明确说明。此外,决策者还应考虑成本效益估计的不确定性。缺乏其他服务使用信息和 SFSW 和 EC 干预成本的微观成本核算削弱了我们的结论。然而,我们的研究具有多个优势,例如基于人群的筛查、大样本量、2 年随访以及使用适当的方法进行全面经济评估。
SFSW 有效减少了儿童的破坏性行为。尽管是数字提供的,但 SFSW 干预措施包含了专业人员的时间,因此也产生了成本。在实施干预措施时,应考虑干预对医疗保健提供者的成本和对家庭的时间成本。SFSW 干预措施的成本效益取决于医疗保健决策者的支付意愿。
投资决策需要对干预措施进行高质量的经济评估,并且应该为干预措施的独立评估研究提供资金。
决策者需要更多关于数字干预措施的经济评估。研究应使用类似的高质量方法,以便在研究之间进行比较。在研究的早期规划阶段,应咨询卫生经济学家,以确保数据的可用性和高质量的研究。